Full-Time
Microbiology Laboratory Scientist
Temp
Confirmed live in the last 24 hours
Pattern Bioscience
51-200 employees
Rapid bacterial infection diagnostics and analysis
Mid, Senior
Austin, TX, USA
- B.S in microbiology or medical technology or related field
- Minimum of 3 years of experience in the Clinical Microbiology Laboratory Setting or other regulated environment (eg CAP, CLIA, FDA, food safety, etc)
- Experience working with BSL-2 microbes
- Knowledge of, and experience with, performing antimicrobial susceptibility testing, MALDI-TOF MS for microorganism identification, and automated blood culture systems, clinical relevant microbes, culture conditions, etc.
- Certification from ASCP or ASCLS, or microbiology specialist certification a plus
- Conduct microbiology reference testing and Pattern assay testing pre-clinical study protocol methods
- Provide microbiology support for successful analytical studies needed for FDA submission
- Support the expansion of the microbial isolate strain bank
- Support lab transition to GLP
- Perform microbiology testing, including culture-based testing, Gram stains, MALDI-TOF MS for microbial identification, and antimicrobial susceptibility testing (including disk diffusion and gradient diffusion methods)
- Draft and review laboratory standard operating procedures
- Perform required quality control of reagents, media, assays, instrumentation etc.
- Perform preventative maintenance on laboratory equipment
- Perform routine laboratory maintenance tasks (such as cleaning, routine temperature monitoring, etc.)
Pattern Bioscience specializes in the rapid identification of bacterial infections and their antibiotic resistance profiles. The company uses advanced digital technology that combines single-cell analysis with artificial intelligence to provide results for identification and antibiotic susceptibility testing in just four hours, a significant reduction from traditional methods that can take days. Its primary customers are hospitals and healthcare providers, including lab directors and infection prevention specialists. Unlike competitors, Pattern Bioscience focuses on delivering faster and more accurate diagnostics, which helps reduce unnecessary antibiotic prescriptions and addresses the critical issue of antibiotic resistance. The company's goal is to improve patient outcomes and combat antibiotic misuse in healthcare settings.
Company Stage
Series C
Total Funding
$115.2M
Headquarters
Austin, Texas
Founded
2016
6 month growth
↓ -1%1 year growth
↑ 5%2 year growth
↑ 53%
Simplify's Take
What believers are saying
- The recent $28.7 million Series C funding will accelerate the development of their innovative diagnostic platform, potentially leading to rapid growth and market penetration.
- The appointment of Carey-Ann Burnham as chief clinical officer brings experienced leadership to drive clinical adoption and credibility.
- Pattern Bioscience's technology can significantly improve patient outcomes and reduce healthcare costs by minimizing the misuse of antibiotics.
What critics are saying
- The healthcare diagnostics market is highly competitive, and Pattern Bioscience must continuously innovate to maintain its edge.
- The reliance on advanced AI and single-cell analysis technology may pose scalability and integration challenges in diverse healthcare settings.
What makes Pattern Bioscience unique
- Pattern Bioscience's use of single-cell analysis combined with AI pattern recognition allows for rapid and accurate bacterial identification and antibiotic susceptibility testing in just four hours, significantly faster than traditional methods.
- The company's focus on combating antibiotic resistance through precise diagnostics positions it uniquely in the healthcare diagnostics market.
- Pattern Bioscience's Digital Culture™ technology offers a first-of-its-kind infectious disease diagnostic platform, setting it apart from competitors.